香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何 損失承擔任何責任。 （於英格蘭及威爾斯成立及註冊的有限責任公司，註冊編號為 01397169 ） （股份代號：2378） 二零二四年第二次中期股息 隨附之公告由 Prudential plc 於以下日期發佈。 承董事會命 Prudential plc Tom Clarkson 公司秘書 二零二五年三月二十日，香港 截至本公告日期，Prudential plc 的董事會成員為： 主席 Shriti Vadera 執行董事 Anil Wadhwani (華康堯) （執行總裁） 獨立非執行董事 Jeremy David Bruce Anderson (安德森) CBE、Arijit Basu、蔡淑君、路明、George David Sartorel、 Mark Vincent Thomas Saunders (馬崇達) FIA, FASHK、Claudia Ricarda Rita Suessmuth ...

Financial Performance - New business profit increased by 11% to $3.078 billion, with traditional embedded value new business profit also growing by 11%[7] - Adjusted profit before tax rose by 10% to $3.129 billion, while adjusted profit after tax increased by 7% to $2.582 billion[7] - Total dividend for 2024 increased by 13% to $0.2313 per share, with total shareholder return for the year amounting to $1.4 billion[7] - Adjusted operating profit for 2024 reached $3,129 million, an 8% increase year-on-year, while adjusted net operating profit after tax was $2,582 million, reflecting a 5% growth[14] - The group’s adjusted post-tax operating profit for 2024 was $2.582 billion, a 7% increase from 2023[40] - The total profit from insurance business is $3.419 billion, showing a 6% growth compared to the previous year[86] - The group’s total adjusted after-tax operating profit is $2.582 billion, a 5% increase from $2.449 billion in the previous year[84] - The total adjusted contract service margin as of December 31, 2024, was $19.2 billion, leading to an adjusted total equity of $36.7 billion, equivalent to $13.79 per share[76] Shareholder Returns - The company plans to complete a $2 billion share buyback program by the end of 2025, ahead of the original schedule[7] - A $2 billion share buyback program was announced, with $785 million already returned to shareholders by December 31, 2024[68] - The total shareholder return for 2024 included dividends of $552 million and share buybacks of $785 million[109] - The estimated excess shareholder surplus over the group's capital requirements was $15.9 billion as of December 31, 2024, with a coverage ratio of 280%[41] Operational Efficiency - The company aims to enhance operational efficiency and meet customer needs through improved claims management and modernized IT infrastructure[6] - The company plans to complete the deployment of its digital service platform PRUServices across seven business units by the end of Q1 2025[9] - The company has enhanced the functionality and consistency of its digital service platform PRUServices, with deployment expected to be completed by the end of Q1 2025 across seven business units[37] - The company aims to increase new business profit from the bank insurance channel by 1.5 to 2 times by 2027, leveraging over 200 banking partners[53] Market Growth and Strategy - The Asian and African markets show clear long-term growth trends, creating significant opportunities for the company[6] - New business profit in banking and insurance increased by 31%, with health and protection products contributing 8% to annual premium equivalent sales[9] - The company is evaluating the potential listing of ICICI Prudential Asset Management Company Limited, which may involve a partial divestment of its stake[7] - The company has established a new partnership with Indonesia's largest Islamic bank, BSI, to expand its distribution network[37] Customer Engagement and Satisfaction - The company achieved a customer net promoter score in the top quartile across five markets, indicating high customer satisfaction[9] - Customer retention rate improved by 1 percentage point to 87% in 2024, with five business units reaching the first quartile in customer net promoter scores[44] - The company launched a health protection plan tailored for mainland Chinese travelers in July 2024, providing comprehensive lifelong coverage through partnerships with over 1,500 healthcare providers in mainland China[60] Risk Management - The company warns of various risks and uncertainties that may affect future financial performance, including geopolitical tensions and regulatory changes[28] - The group faces market risks from interest rates, equity prices, property prices, credit spreads, and currency fluctuations, with a moderate inflation risk primarily from rising medical supply costs[200] - The group maintains capital requirements to ensure sufficient capital above internal and regulatory economic capital requirements, aiming for an ideal credit rating[199] - The group has established procedures for employees to report unethical behavior and violations anonymously[187] Investment and Capital Management - The company plans to invest approximately $1 billion in core capabilities, focusing on customer, distribution, health business, and technology areas[107] - The group anticipates achieving a compound annual growth rate of 15% to 20% in new business profit from 2022 to 2027, with a target operating free surplus of at least $4.4 billion by 2027[74] - The company aims for a risk-adjusted internal rate of return exceeding 25% on new business investments, with a payback period of less than four years[105] Regional Performance - New business profit from health operations reached $346 million in 2024, marking an 11% increase[58] - The new business profit for Hong Kong in 2024 was $1.438 billion, reflecting a 2% increase from $1.411 billion in 2023[127] - In Indonesia, annualized premium equivalent sales decreased by 5% to $262 million, while new business profit increased by 2% to $145 million[133] - In Singapore, annual premium equivalent sales for 2024 reached $870 million, an 11% increase from $787 million in 2023[153] Technology and Innovation - Investment in technology has improved the detection and recovery rates of fraud, waste, and abuse, with a pilot program in Malaysia and Singapore showing a doubling of claims processing automation rates[62] - The company plans to replicate the AI chatbot capabilities, which validated 98% of leads in the Philippines, to Hong Kong, Malaysia, and Vietnam by 2025[54] Corporate Governance - The board expresses confidence in the group's strategy and plans to review investments in new business opportunities and capabilities[113] - The group has established a self-risk and solvency assessment process to identify, measure, manage, and report risks, ensuring capital adequacy at all times[188]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 02378 | 說明 | 普通股每股0.05英鎊 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： Prudential plc 保誠有限公司* (* 僅供識別) 呈交日期： 2025年3月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02378 | 說明 | 普通股每股0.05英鎊 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： Prudential plc 保誠有限公司* (* 僅供識別) | 1). | 購回擬註銷但尚未註銷之股份 | | 260,000 | 0.00989 % | GBP | 7.4531 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年3月13日 | | | | | | 2). | 購回擬註銷但尚未註銷之股份 | | 500,000 | 0.019019 % | GBP | 7.5419 | | | 變動日期 | 2025年3月14日 | | | | | 第 2 頁 共 7 頁 v 1.3.0 FF305 FF305 呈交日期： 2025年3月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A ...

免責聲明 | 香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何 | 聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 | | --- | --- | | | 股票發行人現金股息（可選擇貨幣及以股份代替）公告 | | 發行人名稱 | Prudential plc 保誠有限公司* (* 僅供識別) | | 股份代號 | 02378 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 考慮派發二零二四年第二次中期股息所依據的建議記錄日期 | | 公告日期 | 2025年3月14日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 中期（半年期） | | 股息性質 | 普通股息 | | 財政年末 | 2024年12月31日 | | 宣派股息的報告期末 | 2024年12月31日 | | 宣派股息 | 有待公佈 | | 股東批准日期 | 不適用 | | 預設選項 | 現金 | | 代息股份信息 | | | 現金股 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： Prudential plc 保誠有限公司* (* 僅供識別) 呈交日期： 2025年3月14日 | 1). | 購回擬註銷但尚未註銷之股份 | | 1,500,000 | 0.057035 % | GBP | 7.4491 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年3月12日 | | | | | | 2). | 購回擬註銷但尚未註銷之股份 | | 260,000 | 0.009886 % | GBP | 7.4531 | | | 變動日期 | 2025年3月13日 | | | | | 第 2 頁 共 7 頁 v 1.3.0 FF305 表格類別： 股票 狀態： 新提交 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出 ...

Group 1 - Prudential plc has faced challenges in recent years despite a strong performance in the six months following the last analysis [1] - The company's shares initially outperformed peers, indicating a positive trend during that period [1] Group 2 - No specific financial data or performance metrics were provided in the articles [2]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： Prudential plc 保誠有限公司* (* 僅供識別) 呈交日期： 2025年3月13日 第 2 頁 共 7 頁 v 1.3.0 FF305 FF305 確認 不適用 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 02378 | 說明 | 普通股每股0.05英鎊 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： Prudential plc 保誠有限公司* (* 僅供識別) 呈交日期： 2025年3月12日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02378 | 說明 | 普通股每股0.05英鎊 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | 每股發行 ...